Prof. Gabriele Multhoff heads the research group “Radiation Immuno-Oncology” at the Central Institute for Translational Cancer Research, Klinikum rechts der Isar, TU München (TranslaTUM). For more than 15 years, Prof. Multhoff’s research interests have been in the development of innovative immunotherapies based on NK cells, antibodies, and targeting nanoparticles in combination with radiation therapy. Prof. Multhoff’s research group aims to identify tumor-specific biomarkers for multimodal tumor imaging and theranostic purposes and studies radiation-induced mechanisms in normoxic and hypoxic tumor cells.